Understanding the influence of transfusion and blood loss on tranexamic acid concentration in scoliosis surgery with blood loss. [PDF]
Sá PA +4 more
europepmc +1 more source
On the Effects of Loss of Blood [PDF]
openaire +2 more sources
ABSTRACT Objective To explore how cerebral hypoxia and Normal‐Appearing White Matter (NAWM) integrity affect MS lesion burden and clinical course. Methods Seventy‐nine MS patients, including 13 clinically isolated syndrome (CIS) patients and 66 relapsing–remitting multiple sclerosis (RRMS) patients, and 44 healthy controls (HCs) were recruited from ...
Xinli Wang +8 more
wiley +1 more source
Hidden blood loss estimation using perioperative hemoglobin drop: agreement with the Sehat formula. [PDF]
Ramadanov N +4 more
europepmc +1 more source
Clinical Validation of Plasma p‐217tau in Neurological Diseases
ABSTRACT Objective Plasma p‐217tau is a minimally invasive but specific biomarker for diagnosing Alzheimer's disease (AD). However, its disease specificity remains to be clinically evaluated. We validated the reliability of the p‐217tau biomarker in 12 other neurological diseases.
Takeshi Kawarabayashi +13 more
wiley +1 more source
Machine Learning in Assessing Intraoperative Blood Loss: A Systematic Review and Meta-Analysis. [PDF]
Zhou W, Pan L, Pan X, Li Y, Rao L, Li H.
europepmc +1 more source
A Depolarizing Leak in Sodium Bicarbonate Cotransporter NBCe1 Causes Brain Edema
ABSTRACT Objectives SLC4A4 encodes electrogenic sodium bicarbonate cotransporter NBCe1, prominently expressed in kidney and brain. Recessive loss‐of‐function variants in SLC4A4 cause proximal renal tubular acidosis, no brain edema. In the brain, NBCe1 is expressed by astrocytes, where it regulates pH and mediates astrocyte volume changes.
Quinty Bisseling +16 more
wiley +1 more source
Validation Study of a Photo-Based Menstrual Blood Loss Metric. [PDF]
Fahey J +4 more
europepmc +1 more source
Multiple Sclerosis Relapse Activity After Ozanimod Discontinuation in DAYBREAK Trial Participants
Multiple Sclerosis Relapse Activity After Ozanimod Discontinuation in DAYBREAK Trial Participants. ABSTRACT Objective Return of disease activity is expected when patients discontinue disease‐modifying therapy (DMT) for multiple sclerosis (MS). Some MS DMTs are associated with higher‐than‐expected disease activity (rebound) after discontinuation.
Ralf Gold +12 more
wiley +1 more source
Considerations on the safety of topical hemostatic irrigation in "BLEED-LESS: a scoping review on blood loss elimination in endoscopic decompression". [PDF]
Wang Z, Ying X, Zheng Q.
europepmc +1 more source

